Advertisement

Topics

GIZA VENTURE CAPITAL Company Profile

02:26 EDT 19th June 2018 | BioPortfolio

GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professionals with a wealth of expertise and experience in Communications, Semiconductors, Information Technology, Enterprise Software and Life Sciences.
Giza has invested in 82 companies in the sectors of Communications, Information Technology, Enterprise Software and Life Sciences, with 29 exits. Giza's vision in recognizing future technology leaders led to the following winning investments; Olplus (acquired by Intel, Cyota (acquired by RSA), X Technologies (acquired by Guidant), Precise (NASDAQ:PRSE, acquired by Veritas), Oridion (SWX:ORIDN), Zoran (NASDAQ:ZRAN), M-Systems (NASDAQ:FLSH), DSPG (NASDAQ:DSPG), Butterfly (acquired by TI), DSPC (acquired by Intel), Libit

Location

Ramat Aviv Tower 40 Einstein St. , 12 th floor
Tel Aviv
61172
Israel

Contact

Phone: 972 3 640 2318
Fax: 972 3 640 2319
Email: submitplan@gizavc.com


News Articles [1136 Associated News Articles listed on BioPortfolio]

Codiak closes $76.5mm Series C

Codiak Biosciences Inc. raised $76.5mm through its Series C round to new investors Qatar Investment Authority, Boxer Capital (Tavistock), Sirona Capital, EcoR1 Capital, and Casdin Capital, along with ...

How One Venture Capital Executive Sees the HIT-Fueled Future of Patient Engagement

Mark HaglandJohn Gardner, a partner in the San Francisco-based NGP Capital venture capital firm, shares his perspectives on the role of healthcare IT in the ongoing evolution of the patient engagement...

Venture Investors To Raise As Much As $100M To Fund Health Startups

Venture Investors plans to raise up to $100 million for a new, healthcare-focused venture capital fund, the Madison, WI-based firm said in a document recently filed with federal securities regulators....

Foresite Capital Launches New Venture Capital Fund Worth $668 Million

Venture capital firm Foresite Capital, located in San Francisco, is launching a new fund, its fourth and largest, worth $668 million.

Causeway Sensors gets nearly $1.7M boost from Irish venture capital fund

Kernel Capital, the Bank of Ireland's venture capital fund, has invested nearly $1.7 million in Causeway Sensors, the medtech -More- 

San Diego VC Funding Hits $547.2M in Q1; Ideaya Leads Top 10 Deals

Venture capital investors sank $547.2 million into 37 startup companies throughout San Diego County during the first three months of 2018, maintaining roughly the same level of venture funding seen in...

Renault-Nissan-Mitsubishi Launches a Venture Capital Fund to Invest up to $1 Billion Over Five Years

New entity to act asmaininterface for start-ups, investors and the venture capital ecosystem  Fund prioritizesopeninnovation in new mobility, Read more...

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

PubMed Articles [129 Associated PubMed Articles listed on BioPortfolio]

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Clinical Trials [52 Associated Clinical Trials listed on BioPortfolio]

Prevalence of NNSH in a Group of Egyptian Children Aged 3-8 Years Old in Giza Governorate: A Cross Sectional Study.

1. Prevalence of non-nutritive sucking habits (NNSH) in a group of Egyptian children aged 3-8 years old in Giza Governorate. 2. Assessment of factors associated with NNSH.

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Prevalence of Molar Incisor Hypomineralization Among a Group of Egyptian Children in Giza Governorate

- One single operator will assess the prevalence of molar incisor hypomineralization and its Severity among a group of Egyptian children in Giza Governorate .

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Companies [1601 Associated Companies listed on BioPortfolio]

GIZA VENTURE CAPITAL

GIZA VENTURE CAPITAL established in 1992, is a pioneer investor in seed and early-stage technology companies. Giza currently manages four funds totaling about $500 million.Giza has investment professi...

BVK Bundesverband Deutscher Kapitalbeteiligungsgesellschaften German Private Equity and Venture Capital Association e.V.

Bundesverband Deutscher Kapitalbeteiligungsgesellschaften – German Private Equity and Venture Capital Association e.V. (BVK) is the organisation of German venture capital and private equity companie...

Russian Venture Capital Association

The idea to create Russian Venture Capital Association had been expressed at the December 1996 seminar for EBRD regional venture capital fund managers in St.-Petersburg. The RVCA founding meeting was ...

EUROPEAN INVESTMENT FUND

The EIF's activity is centred upon two areas, venture capital and guarantees: EIF's venture capital instruments consist of equity investments in venture capital funds and business incubators that supp...

Morgenthaler

David Morgenthaler founded the firm in 1968 after a successful career as an operating executive. After his venture-backed business was sold to an international company, Dave decided that there was a t...

More Information about "GIZA VENTURE CAPITAL" on BioPortfolio

We have published hundreds of GIZA VENTURE CAPITAL news stories on BioPortfolio along with dozens of GIZA VENTURE CAPITAL Clinical Trials and PubMed Articles about GIZA VENTURE CAPITAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GIZA VENTURE CAPITAL Companies in our database. You can also find out about relevant GIZA VENTURE CAPITAL Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record